Search alternatives:
point decrease » point increase (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1561
-
1562
Unusual [3+1] Cycloaddition of a Stable Silylene with a 2,3-Diazabuta-1,3-diene versus [4+1] Cycloaddition toward a Buta-1,3-diene
Published 2010“…Cycloaddition reactions of the thermally stable N-heterocyclic silylene LSi: <b>1</b> {L = CH[(CCH<sub>2</sub>)CMe][N(Ar)]<sub>2</sub>], Ar = 2,6-<i>i</i>Pr<sub>2</sub>C<sub>6</sub>H<sub>3</sub>} with acetone azine (1,1,4,4-tetramethyl-2,3-diazabuta-1,3-diene) and buta-1,3-diene derivatives have been probed. …”
-
1563
-
1564
-
1565
-
1566
-
1567
-
1568
-
1569
m<sup>5</sup>C modified sites contributes to HBV replication in cccDNA-like system.
Published 2023Subjects: -
1570
Cytotoxic effect of Eltrombopag on AML cells is dependent on dose and serum concentration.
Published 2015“…Graphs demonstrate decrease in a total cell number after exposure to 5 μM E at 2% serum, presented as a percent of control at day 2 for cell lines and day 4 for primary cells.…”
-
1571
-
1572
-
1573
Decreased clonal burden in relapses over time.
Published 2022“…Similarly, relapses in 18 Cambodian soldiers determined genotypically to have relapse <a href="https://paperpile.com/c/lfW4ac/V4Y4V" target="_blank">[13</a>] suggest a decrease in MOI from their initial vivax episode to relapse (slope = -0.03, p = 0.20). …”
-
1574
-
1575
-
1576
-
1577
Table_5_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx
Published 2022“…</p>Results<p>To the best to our knowledge, we present for the first time an overview of the genomic mutation spectrum of early-stage laryngeal cancers. A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”
-
1578
-
1579
-
1580